Table 2. Baseline characteristics and demographic data of patients with pCR.

Patient	Age	Menopausal status	Tumor staging	Nodal staging	Histological subtype	Histological grade	HER2	Pretreatment Ki67	Treatment
1	48	pre	T3	N1	ductal	III	negative	80	AC-T
2	50	pre	T2	N2	ductal	III	positive	70	AC-T
3	56	post	T2	N0	ductal	III	negative	70	AC-T
4	49	post	T3	N2	ductal	III	positive	30	AC-T
5	40	pre	T3	N1	ductal	III	positive	20	AC-T
6	43	pre	T3	N1	ductal	III	positive	15	AC-T
7	40	pre	T3	N1	ductal	III	positive	20	AC-T
8	32	pre	T2	N0	ductal	III	negative	15	AC-T

Abbreviations: AC, doxorubicin plus cyclophosphamide; ER, estrogen receptor; HER2, human epidermal growth factor receptor 2; pCR, pathologic complete response; PR, progesterone receptor; T, paclitaxel or docetaxel.